The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.45
Bid: 2.44
Ask: 2.46
Change: -0.05 (-2.00%)
Spread: 0.02 (0.82%)
Open: 2.50
High: 0.00
Low: 0.00
Prev. Close: 2.50
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Globalworth Real Estate

23 Jun 2021 11:18

RNS Number : 8538C
JPMorgan Securities Plc
23 June 2021
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Globalworth Real Estate Investments Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

financial advisor to Globalworth Real Estate Investments Limited

(d) Date dealing undertaken:

22 June 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Share

Purchase

 

Sale

6,774

 

-

7.3055 EUR

 

-

7.3055 EUR

 

-

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Share

Equity Swap

 

Increase Short

6,774

7.3055 EUR

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

23 June 2021

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERPPUMGQUPGGUW
Date   Source Headline
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.